insights_auto
Why is CSBR down 2,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,49 $
arrow_downward
-2,21%(-0,10) 1D
18 նոյ, 10:42:24 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 $
High
4,60 $
Low
4,49 $
Mkt. cap
62,52 մլն
Avg. vol.
7,41 հզր
Volume
3,68 հզր
52-wk high
8,31 $
52-wk low
4,49 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,55 $
High
4,60 $
Low
4,49 $
Mkt. cap
62,52 մլն
Avg. vol.
7,41 հզր
Volume
3,68 հզր
52-wk high
8,31 $
52-wk low
4,49 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
40 րոպե առաջ
S&P 500 Gap-Down Movers for Nov. 18 Session
TradingView
·
37 րոպե առաջ
S&P 500, Nasdaq find footing as Nvidia treads water
Coinpaper
·
1 ժամ առաջ
Dow Jones: Wall Street Eyes Rebound as Morgan Stanley Targets S&P 500 at 8,700
FOREX.com
·
4 ժամ առաջ
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com